This content is from: Premium

The Morning Brief: Baupost’s Biotech Bets Go Ballistic

Two of Baupost Group’s recent biotech investments enjoyed big bounces Wednesday. Shares of Paratek surged 17.4 percent, to $34, on more than quadruple the stock’s average daily volume. The stock has now virtually doubled in just the past eight trading days. We recently reported that Boston-based Baupost disclosed that it

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content